Skip to main content
. 2020 Jan 23;12(2):280. doi: 10.3390/cancers12020280

Figure 2.

Figure 2

SDHB deficiency activated NRF2-driven glutathione synthetic pathway. (A) antioxidative response element (ARE)-luciferase reporter assay showed increased NRF2 activity in SDHBKD MPC and hpheo1 cells. *** p < 0.001. (B) Quantitative real-time PCR showed increased gene transcription of NRF2-associated genes Gclm and Slc7a11 in SDHBKD MPC cells. *** p < 0.001. (C) Immunoblotting showed increased expression of NRF2 and its downstream targets in SDHBKD MPC and hpheo1 cells. β-actin was used as internal control. (D) Cycloheximide (CHX) pulse chase assay showed elevated NRF2 protein stability in SDHBKD hpheo1 cells. β-actin was used as internal control. (E) Quantification of NRF2 half-life from Figure 2D. (F) Chromatin immunoprecipitation (ChIP) PCR assay showed increased promoter affinity of NRF2 in SDHBKD hpheo1 cells. * p < 0.05; ** p < 0.01; *** p < 0.001.